Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Chioncel O, Mebazaa A, Farmakis D, Abdelhamid M, Lund LH, Harjola VP, Anker S, Filippatos G, Ben-Gal T, Damman K, Skouri H, Antohi L, Collins SP, Adamo M, Miro O, Hill L, Parissis J, Moura B, Mueller C, Jankowska E, Lopatin Y, Dunlap M, Volterrani M, Fudim M, Flammer AJ, Mullens W, Pang PS, Tica O, Ponikowski P, Ristic A, Butler J, Savarese G, Cicoira M, Thum T, Bayes Genis A, Polyzogopoulou E, Seferovic P, Yilmaz MB, Rosano G, Coats AJS, Metra M

Open source

DOI
10.1002/ejhf.3673
Published
2025 Jun
Container
European journal of heart failure
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ejhf.3673,
  title = {Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).},
  author = {Chioncel O and Mebazaa A and Farmakis D and Abdelhamid M and Lund LH and Harjola VP and Anker S and Filippatos G and Ben-Gal T and Damman K and Skouri H and Antohi L and Collins SP and Adamo M and Miro O and Hill L and Parissis J and Moura B and Mueller C and Jankowska E and Lopatin Y and Dunlap M and Volterrani M and Fudim M and Flammer AJ and Mullens W and Pang PS and Tica O and Ponikowski P and Ristic A and Butler J and Savarese G and Cicoira M and Thum T and Bayes Genis A and Polyzogopoulou E and Seferovic P and Yilmaz MB and Rosano G and Coats AJS and Metra M},
  year = {2025},
  journal = {European journal of heart failure},
  doi = {10.1002/ejhf.3673},
  url = {https://doi.org/10.1002/ejhf.3673}
}

RIS

TY  - JOUR
TI  - Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
AU  - Chioncel O
AU  - Mebazaa A
AU  - Farmakis D
AU  - Abdelhamid M
AU  - Lund LH
AU  - Harjola VP
AU  - Anker S
AU  - Filippatos G
AU  - Ben-Gal T
AU  - Damman K
AU  - Skouri H
AU  - Antohi L
AU  - Collins SP
AU  - Adamo M
AU  - Miro O
AU  - Hill L
AU  - Parissis J
AU  - Moura B
AU  - Mueller C
AU  - Jankowska E
AU  - Lopatin Y
AU  - Dunlap M
AU  - Volterrani M
AU  - Fudim M
AU  - Flammer AJ
AU  - Mullens W
AU  - Pang PS
AU  - Tica O
AU  - Ponikowski P
AU  - Ristic A
AU  - Butler J
AU  - Savarese G
AU  - Cicoira M
AU  - Thum T
AU  - Bayes Genis A
AU  - Polyzogopoulou E
AU  - Seferovic P
AU  - Yilmaz MB
AU  - Rosano G
AU  - Coats AJS
AU  - Metra M
PY  - 2025
JO  - European journal of heart failure
DO  - 10.1002/ejhf.3673
UR  - https://doi.org/10.1002/ejhf.3673
ER  - 

APA

O, C., A, M., D, F., M, A., LH, L., VP, H., S, A., G, F., T, B., K, D., H, S., L, A., SP, C., M, A., O, M., L, H., J, P., B, M., C, M., E, J., Y, L., M, D., M, V., M, F., AJ, F., W, M., PS, P., O, T., P, P., A, R., J, B., G, S., M, C., T, T., A, B. G., E, P., P, S., MB, Y., G, R., AJS, C., & M, M. (2025). Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).. European journal of heart failure. https://doi.org/10.1002/ejhf.3673

Source records